States Back Off Bid To Block Sandoz Spinoff In Antitrust Case
Novartis AG completed the planned spinoff of its Sandoz unit on Wednesday, after state enforcers and others withdrew their bid to block the move over concerns about recovering alleged overcharges from...To view the full article, register now.
Already a subscriber? Click here to view full article